SCHEMBL1476638

SCHEMBL1476638

O=C(NCCN1CCN(c2ccc(Cl)cc2)CC1)c1cc(-c2ccco2)on1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.60
KMT2A Q03164 3/20 0.60
MAPT P10636 3/20 0.60
MEN1 O00255 2/20 0.60
MAPK1 P28482 1/20 0.60
HTT P42858 1/20 0.60
HTR1A P08908 2/20 0.56
LMNA P02545 4/20 0.56
RAB9A P51151 4/20 0.56
NPC1 O15118 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
TP53 P04637 1/20 0.56
GAA P10253 1/20 0.56
HPGD P15428 1/20 0.56
DRD2 P14416 3/20 0.55
POLB P06746 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
DRD4 P21917 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1474960 0.91 ALDH1A1 (0.64) ALDH1A1KMT2AMAPTMEN1HTT
SCHEMBL1475081 0.90 SMN1; SMN2 (0.60) ALDH1A1KMT2AMAPTMEN1HTR1A
SCHEMBL1476629 0.90 ALDH1A1 (0.62) ALDH1A1KMT2AMAPTMEN1HTT
SCHEMBL1475255 0.88 ALDH1A1 (0.62) ALDH1A1KMT2AMAPTMEN1HTT
SCHEMBL1475690 0.87 RAB9A (0.53) ALDH1A1KMT2AMAPTMEN1MAPK1
SCHEMBL15190298 0.85 DRD2 (0.47) ALDH1A1KMT2AMAPTMEN1MAPK1
SCHEMBL1474506 0.85 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTMEN1HTT
SCHEMBL1477101 0.85 RAB9A (0.67) ALDH1A1KMT2AMAPTMEN1MAPK1
SCHEMBL1474419 0.85 LMNA (0.72) ALDH1A1KMT2AMAPK1HTTLMNA
SCHEMBL27176294 0.85 RAB9A (0.67) ALDH1A1KMT2AMAPTMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131336-A1 Isoxazole Derivatives and Use Thereof WNT3A, WNT1, WNT3 ALDH1A1 706/4885KMT2A 4661/4885MAPT 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.